Ascendis Pharma A/S (ASND)
243.37
+0.38
(+0.16%)
USD |
NASDAQ |
Oct 23, 16:00
243.25
-0.12
(-0.05%)
After-Hours: 20:00
Ascendis Pharma Market Cap : 15.98B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 15.98B |
| October 22, 2026 | 15.96B |
| October 21, 2026 | 15.69B |
| October 20, 2026 | 15.39B |
| October 19, 2026 | 15.10B |
| October 16, 2026 | 14.79B |
| October 15, 2026 | 14.88B |
| October 14, 2026 | 14.91B |
| October 13, 2026 | 14.66B |
| October 12, 2026 | 14.91B |
| October 09, 2026 | 15.05B |
| October 08, 2026 | 14.62B |
| October 07, 2026 | 15.00B |
| October 06, 2026 | 14.85B |
| October 05, 2026 | 14.98B |
| October 02, 2026 | 14.96B |
| October 01, 2026 | 14.93B |
| September 30, 2026 | 14.96B |
| September 29, 2026 | 14.98B |
| September 28, 2026 | 15.11B |
| September 25, 2026 | 14.82B |
| September 24, 2026 | 15.15B |
| September 23, 2026 | 14.65B |
| September 22, 2026 | 15.60B |
| September 21, 2026 | 15.60B |
| Date | Value |
|---|---|
| September 18, 2026 | 15.55B |
| September 17, 2026 | 15.70B |
| September 16, 2026 | 16.27B |
| September 15, 2026 | 15.75B |
| September 14, 2026 | 17.40B |
| September 11, 2026 | 17.31B |
| September 10, 2026 | 17.16B |
| September 09, 2026 | 17.13B |
| September 08, 2026 | 17.74B |
| September 04, 2026 | 17.77B |
| September 03, 2026 | 17.81B |
| September 02, 2026 | 17.56B |
| September 01, 2026 | 17.09B |
| August 31, 2026 | 17.27B |
| August 28, 2026 | 16.28B |
| August 27, 2026 | 16.38B |
| August 26, 2026 | 16.43B |
| August 25, 2026 | 16.61B |
| August 24, 2026 | 16.55B |
| August 21, 2026 | 16.63B |
| August 20, 2026 | 16.73B |
| August 19, 2026 | 17.05B |
| August 18, 2026 | 16.34B |
| August 17, 2026 | 16.25B |
| August 14, 2026 | 16.32B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 10.83B |
| Novo Nordisk A/S | 130.66B |
| Evaxion AS | 31.36M |
| Genmab A/S | 26.14B |
| Zealand Pharma A/S | 2.365B |
Market Cap Related Metrics
| PE Ratio | 18.54 |
| PS Ratio | 12.71 |
| Price to Book Value | 9.732 |
| Price to Free Cash Flow | 39.90 |
| Price | 243.37 |
| Earnings Yield | 5.39% |
| Operating PE Ratio | 123.17 |
| Normalized PE Ratio | 18.54 |